 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
|
|
| |
| Company Profile |
| |
|
Embrex, Inc., an agricultural biotechnology company, provides solutions to the poultry industry in the United States. It focuses on developing patented biological and mechanical products that improve bird health. The company principally engages in the development of in ovo (in the egg) solutions that meet the needs of the poultry industry. Embrex has developed and commercialized the Inovoject system, a proprietary, automated in-the-egg injection system, which can inoculate 20,000 to 50,000 eggs per hour and eliminates the need for manual post-hatch injection of certain vaccines. In addition, Embrex markets its AAC technology, which is useful in the development of certain avian vaccines. The company also markets Bursaplex, a vaccine based on AAC technology, for protection against avian infectious bursal disease. Embrex was incorporated in 1985 and is based in Durham, North Carolina.
|
EMBREX INC Related |
|
Embrex Develops biological and mechanical products including in ovo platform delivery systems that improve poultry health and reduce production costs.
|
|
Embrex, Inc.: Information from Answers.com Company Perspectives: The potential of Embrex's technology is significant. ... He incorporated Embrex in North Carolina in May 1985. ...
|
|
Embrex, Inc. Company Profile - Yahoo! Finance Capsule info for Embrex, Inc. ... Industry Center > Farm Products > Embrex, Inc. Company Profile. Summary. News. Leaders & Laggards ...
|
|
|
|
|
